Zeptriva 30mg 2ml

PEP for Injection is a first-in-class, once-weekly glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) receptor agonist. It is indicated for the treatment of adults with type 2 diabetes mellitus to improve glycemic control, as well as for chronic weight management in individuals with obesity or overweight with at least one weight-related comorbidity.

As a dual incretin agonist, PEP uniquely activates both GLP-1 and GIP receptors, providing superior reductions in hemoglobin A1c (HbA1c) and body weight compared to selective GLP-1 receptor agonists. The product enhances glucose-dependent insulin secretion, suppresses glucagon release, delays gastric emptying, and reduces appetite via central mechanisms.

PEP for Injection is supplied as a sterile, preservative-free, clear and colorless solution in a single-dose pen or vial. It is administered via subcutaneous injection once weekly, with or without meals.

Please refer to the full prescribing information for contraindications, warnings (including risk of thyroid C‑cell tumors), and potential adverse reactions such as nausea, diarrhea, and vomiting.